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Abstract: Zinc chloride is an important pharmaceutical/nutraceutical compound used as a source of zinc. The objective of 
the current study was to investigate the impact of The Trivedi Effect®-Energy of Consciousness Healing Treatment 
(Biofield Energy Treatment) on physical, structural, thermal, and behavioral properties of zinc chloride using PXRD, PSD, 
FT-IR, UV-vis, and DSC analysis. Zinc chloride was divided into two parts – one part was control, while another part was 
treated with The Trivedi Effect® remotely by seven renowned Biofield Energy Healers and defined as The Trivedi Effect® 
Treated sample. A significant alteration of the crystallite size and relative intensities of the PXRD peaks was observed in 
The Trivedi Effect® treated sample compared with the control sample. A sharp peak at 2θ equal to 16.58° was observed in 
the control sample, but it was disappeared in the treated sample. The average crystallite size of the treated sample was 
significantly reduced by 21.31% compared with the control sample. The particle size values at d10, d50, and d90 were 
significantly decreased by 8.15%, 6.28%, and 5.26%, respectively in the treated sample compared with the control sample. 
The surface area of the treated sample was significantly increased by 7.14% compared with the control sample. The FT-IR 
spectroscopic analysis revealed that Zn-Cl stretching in the control and treated sample were found at 510 cm-1 and 511 cm-1, 
respectively. The UV-vis analysis exhibited that wavelength of the maximum absorbance (λmax) of both the control and 
treated samples was at 196 nm. The DSC analysis exhibited that the melting and decomposition temperature were decreased 
by 0.29% and 0.28%, respectively in the treated zinc chloride compared to the control sample. The latent heat of fusion of 
the treated sample (370.48 J/g) was increased significantly by 97.71% compared with the control sample (187.39 J/g). This 
results indicated that zinc chloride need more heat energy to undergo the process of melting after Biofield Energy 
Treatment. The enthalpy of decomposition of the treated sample was significantly decreased by 15.40% compared with the 
control sample. The current study anticipated that The Trivedi Effect®-Energy of Consciousness Healing Treatment might 
lead to produce a new polymorphic form of zinc chloride, which would be more soluble, bioavailable and latent heat of 
fusion compared with the untreated compound. Hence, the treated zinc chloride would be very useful to design better 
nutraceutical/pharmaceutical formulations that might offer better therapeutic response against inflammatory diseases, 
immunological disorders, aging, stress, cancer, etc. 
Keywords: Zinc Chloride, Biofield Energy Healing Treatment, Consciousness Energy Healing Treatment,  
Biofield Energy Healers, The Trivedi Effect®, PXRD, Particle Size, DSC 
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1. Introduction 
Zinc is an essential element in human and animal nutrition 
for its broad spectrum of biological activities. It plays an 
important role in catalytic, structural or regulation in 
enzymes in our body, which involved in the nucleic acid and 
protein metabolism as well as for the production of energy. 
Zinc also maintains the structural integrity of the biological 
membranes resulting in their protection against oxidative 
injury [1-2]. As a metallotherapeutic agent, zinc possesses 
various pharmacological activities include fertility 
enhancing, retino-protective, and putative antiviral activities 
[3]. Zinc is also used in the treatment of Wilson’s disease [4]. 
It has also immunomodulatory and antioxidant activities [1]. 
Zinc is also used to prevent the development of several 
deficiency symptoms include parakeratosis, hypogeusia, 
anorexia, dysosmia, geophagia, hypogonadism, growth 
retardation, etc. [5-7]. Recently, it has been reported that zinc 
had increased the leukocyte count and phagocytic index, 
which potentiate the immunomodulatory effect along with 
Glycyrrhiza glabra [8]. Zinc chloride (ZnCl2) is hygroscopic 
inorganic salt and highly soluble in water [9]. It is sometimes 
used in pharmaceutical industry as drug and diagnostic agent 
due to its powerful astringent and mild antiseptic properties 
[10]. It is also used in mouth-wash and deodorant 
preparations. Zinc chloride is used as dentin desensitizer i.e. 
reduces the sensitivity of the teeth to heat and cold. The other 
applications of zinc chloride include protein precipitation and 
insulin preparation [10, 11]. Literature reported that zinc 
chloride has also been used in the treatment of cancer as a 
destructive agent [12] and in the pluripotency maintenance of 
mouse embryonic stem cell through the regulation of STAT3 
signaling pathway [13]. It can be used for the palliative 
treatment of canine and malignant skin wounds [14]. It has 
the opposite effect on locomotor behavior of rats [15]. 
Therefore, zinc chloride was considered as one of the 
component in the novel proprietary herbomineral formulation 
for the source of zinc ion. This herbomineral formulation is 
designed as nutraceutical supplement, and can be used for the 
prevention and treatment of various human disorders.  
An élan vital or vital force which contributes the ‘life’ is 
preserved by every living organisms and known as prana by 
the Hindus, qi or chi by the Chinese, and ki by the Japanese. 
This is believed to co-relate with the soul, spirit and mind. 
This hypothetical vital force is considered as the Biofield 
Energy. The Biofield Energy is infinite, paradimensional and 
dynamic electromagnetic field surrounding the human body. 
It can freely flow between the human and environment that 
leads to the continuous movement or matter of energy [16, 
17]. Thus, a human has the ability to harness energy from the 
earth, the “universal energy field” and transmit it to any 
living or nonliving object(s) around the globe. The objects 
always receive the energy and respond in a useful way. This 
process is known as Biofield Energy Healing Treatment [18, 
19]. Biofield (Putative Energy Fields) based Energy 
Therapies are used worldwide to promote health and healing. 
The National Center of Complementary and Integrative 
Health (NCCIH) has been recognized and accepted Biofield 
Energy Healing as a Complementary and Alternative 
Medicine (CAM) health care approach in addition to other 
therapies, medicines and practices such as natural products, 
deep breathing, yoga, Tai Chi, Qi Gong, 
chiropractic/osteopathic manipulation, meditation, massage, 
special diets, homeopathy, progressive relaxation, guided 
imagery, acupressure, acupuncture, relaxation techniques, 
hypnotherapy, healing touch, movement therapy, pilates, 
rolfing structural integration, mindfulness, Ayurvedic 
medicine, traditional Chinese herbs and medicines, 
naturopathy, essential oils, aromatherapy, Reiki, cranial 
sacral therapy and applied prayer (as is common in all 
religions, like Christianity, Hinduism, Buddhism and 
Judaism) [20]. Biofield Energy Treatment (The Trivedi 
Effect®) has been reported in numerous peer-reviewed 
science journals with significant outcomes in many scientific 
fields such as cancer research [21]; altered antimicrobial 
sensitivity of pathogenic microbes in microbiology [22-24], 
biotechnology [25, 26], genetics [27, 28]; changing the 
structure of the atom in relation to various metals, ceramics, 
polymers and chemicals in materials science [29, 30], altered 
physical and chemical properties of pharmaceuticals [31, 32], 
nutraceuticals [33, 34], organic compounds [35-37], and 
improved overall growth and yield of plants in agricultural 
science [38, 39]. The physicochemical properties such as 
particle size, crystalline structure, crystallite size, surface 
area, and thermal properties of a drug have a vital role in 
bioavailability as well as stability of the drug during 
processing, formulation, storage, and packaging [40, 41]. The 
particle size, specific surface area, crystalline nature, 
chemical and thermal behavior of an atom/ion might be 
altered by the Biofield Energy Healing Treatment (The 
Trivedi Effect®) through possible mediation of neutrinos 
[42]. By considering all these aspects, powder X-ray 
diffraction (PXRD), particle size distribution analysis (PSD), 
Fourier transform infrared (FT-IR) spectrometry, ultraviolet-
visible (UV-vis) spectroscopy, and differential scanning 
calorimetry (DSC) analytical techniques were conducted in 
this study for the characterization of physical, structural, and 
thermal properties of the Biofield Energy Treated and 
untreated zinc chloride. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Zinc chloride was procured from Tokyo Chemical Industry 
Co., Ltd. (TCI), Japan. All other chemicals used in the 
experiment were of analytical grade available in India. 
2.2. The Trivedi Effect
®
 - Energy Healing Treatment 
Strategies 
Zinc chloride was one of the components of the new 
proprietary herbomineral formulation, developed by our 
research team and it was used per se as the test compound for 
the current study. The test compound was divided into two 
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parts, one part of the test compound did not receive any sort 
of treatment and was defined as the untreated or control zinc 
chloride sample. The second part of the test compound was 
treated with The Trivedi Effect® - Energy of Consciousness 
Healing Treatment (Biofield Energy Treatment) by a group 
of seven renowned Biofield Energy Healers remotely and 
was denoted as Biofield Energy Treated or The Trivedi 
Effect® sample. All seven Biofield Energy Healers were 
remotely located in the U.S.A., while the test compound was 
located in the research laboratory of GVK Biosciences Pvt. 
Ltd., Hyderabad, India. This Biofield Energy Treatment was 
provided for 5 minutes through Healer’s Unique Energy 
Transmission process remotely to the test compound under 
the laboratory conditions. None of the Biofield Energy 
Healers in this study visited the laboratory in person, nor had 
any contact with the compounds. Similarly, the control 
compound was subjected to “sham” healers for 5 minutes, 
under the same laboratory conditions. The sham healer did 
not have any knowledge about the Biofield Energy 
Treatment. After that, the Biofield Energy Treated and 
untreated samples were kept in similar sealed conditions and 
characterized thoroughly by PXRD, PSD, FT-IR, UV-visible 
spectroscopy, and DSC analysis. 
2.3. Characterization 
2.3.1. Powder X-Ray Diffraction (PXRD) Analysis 
The PXRD analysis was accomplished on PANalytical 
X’Pert Pro powder X-ray diffractometer system. The X-ray 
of wavelength 1.54056 Å was used. The data was collected in 
the form of a chart of the Bragg angle (2θ) vs. intensity, and a 
detailed table containing information on peak intensity 
counts, d value (Å), relative intensity (%), full width half 
maximum (FWHM) (θ°). From the PXRD results, the 
crystallite size (G) was calculated using X’Pert data collector 
and X’Pert high score plus processing software. The 
crystallite size (G) was calculated from the Scherrer equation 
[43, 44]. The method was based on the width of the 
diffraction patterns obtained in the X-ray reflected the 
crystalline region. The crystallite size (G) was calculated by 
using the following formula (1): 
G = kλ/(bCosθ)                               (1) 
Where, k is the equipment constant (0.5), λ is the X-ray 
wavelength (0.154 nm); b in radians is the full-width at half 
of the peaks and θ the corresponding Bragg angle. 
Percent change in crystallite size (G) was calculated using 
following equation (2): 
%	change	in	crystallite	size	 =
		
	
× 100  (2) 
Where, GControl and GTreated are the crystallite size of the 
control and Biofield Energy Treated samples, respectively. 
A total of ~500 mg of the control and Biofield Energy 
Treated samples individually were used for the analysis and 
prepared by back loading technique using the sample 
preparation kit. The sample was spread on the holder ring in 
sufficient quantity to fill the ring cavity. It was then pressed 
down using powder press block and scrap the powder that 
was in surplus using a glass slide to get densely packed 
specimen. Consequently, the bottom plate was placed onto 
the holder ring and clamp in position. The sample holder was 
then removed from the sample preparation table by turning it 
upside down. A smooth surface of sample was obtained to 
ensure optimum results. 
2.3.2. Particle Size Distribution (PSD) Analysis 
The average particle size and particle size distribution 
were analyzed using Malvern Mastersizer 2000, UK with 
a detection range between 0.01 µm to 3000 µm. The 
sample unit was filled with the dispersant medium and 
operated the stirrer at 2500 rpm. Alignment of the optics 
was done and the background measurement was taken. 
After the background measurement, the sample was added 
into the sample unit with constant monitoring the 
obscuration and stopped the addition of sample when the 
obscuration reached in between 15% to 20%. When the 
obscuration was stable, the measurement was taken twice 
and the average of two measurements was taken. The 
average histogram of the two measurements was recorded. 
The data was presented in table format which include 
particle size (µm). Also, the values at below 10% level 
(d10), 50% level (d50), and 90% level (d90) were calculated 
from the histogram and the calculations such as surface 
area (m2/g) were done by using software Mastersizer 
2000. 
Percent change in particle size (d) for at below 10% level 
(d10), 50% level (d50), and 90% level (d90) was calculated 
using following equation (3): 
%	change	in	particle	size =
##
#
× 100   (3) 
Where, dControl and dTreated are the particle size (µm) for at 
below 10% level (d10), 50% level (d50), and 90% level (d90) 
of the control and Biofield Energy Treated samples, 
respectively. 
Percent change in surface area (S) was calculated using 
following equation (4): 
%	change	in	surface	area =
&	&	
&	
× 100   (4) 
Where, SControl and STreated are the surface area of the 
control and Biofield Energy Treated samples, respectively. 
2.3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
FT-IR spectroscopy of zinc chloride was performed on 
Spectrum two (Perkin Elmer, USA) Fourier transform 
infrared spectrometer with the frequency array of 400-4000 
cm-1 by using pressed KBr disk technique. 
2.3.4. Ultraviolet-Visible Spectroscopy (UV-Vis) Analysis 
The UV-Vis spectral analysis was carried out using Shimadzu 
UV-2450 with UV Probe, Japan. The spectrum was recorded 
using 1 cm quartz cell that has a slit width of 1.0 nm. The 
wavelength range chosen for recording the spectra was 190-800 
nm. The absorbance spectra (in the range of 0.2 to 0.9) and 
wavelength of maximum absorbance (λmax) were recorded. 
 World Journal of Applied Chemistry 2017; 2(2): 57-66  60 
 
2.3.5. Differential Scanning Calorimetry (DSC) 
Analysis was performed using the DSC Q20 (TA 
Instruments, USA) differential scanning calorimeter. A total 
of ~5 mg sample was weighed and sealed in aluminum pans 
and equilibrated at 25°C and heated up to 450ºC at the 
heating rate of 10ºC/min under nitrogen gas as purge 
atmosphere with flow rate of 50 mL/min. The value for 
onset, endset, peak temperature, peak height (mJ or mW), 
peak area, and change in heat (J/g) for each peak were 
recorded. 
Percent change in the decomposition temperature (T) was 
calculated using following equation (5): 
%	change	in	decomposition	temperature 
**
*
 100                                (5) 
Where, TControl and TTreated are the decomposition 
temperature of the control and Biofield Energy Treated 
samples, respectively. 
Percent change in the enthalpy of decomposition (∆H) was 
calculated using following equation (6): 
	%	change	in	enthalpy	of	decomposition 
+,-,
-,
 100                           (6) 
Where, ∆HControl and ∆HTreated are the enthalpy of 
decomposition of the control and Biofield Energy Treated 
samples, respectively. 
3. Results and Discussion 
3.1. Powder X-Ray Diffraction (PXRD) Analysis 
The PXRD diffractograms of both the control and 
Biofield Energy Treated zinc chloride are shown in the 
Figure 1. Both the samples displayed very sharp and 
intense peaks in their respective diffractogram indicating 
the crystalline nature of zinc chloride. PXRD data such as 
Bragg angle (2θ), relative intensity (%), full width half 
maximum (FWHM) (θ°), and crystallite size (G) for the 
control and Biofield Energy Treated zinc chloride are 
presented in the Table 1. The crystallite size was 
calculated with the help of Scherrer equation [43, 44]. The 
crystallite size of the control and Biofield Energy Treated 
samples were found similar at 2θ equal to nearly 15.6°, 
34.9°, and 79.0° (Table 1, entry 1, 4, and 14). 
Consequently, the crystallite size of the Biofield Energy 
Treated zinc chloride at 2θ equal to nearly 38.3° and 56.2° 
(Table 1, entry 5 and 9) was significantly increased by 
67% and 75%, respectively compared with the control 
sample. On the other hand, the crystallite size of the 
Biofield Energy Treated zinc chloride at 2θ equal to nearly 
25.5°, 29.4°, 48.7°, 49.2°, 52.3°, 58.4°, 61.7°, 63.2°, 
72.2°, and 92.0° (Table 1, entry 2, 3, 6-8, 10-13, and 15) 
was significantly decreased in the range of 17% to 75% 
with respect to the control sample. However, the average 
crystallite size of the Biofield Energy Treated sample was 
significantly reduced by 21.31% (Table 1, entry 16) 
compared with to the control sample.  
 
Figure 1. PXRD diffractogram of the control and Biofield Energy Treated zinc chloride. 
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Table 1. PXRD data of the control and Biofield Energy Treated zinc chloride. 
Entry No. 
Bragg angle (°2θ) Relative Intensity (%) FWHM (°2θ) Crystallite size (G, nm) 
Control Treated Control Treated Control Treated Control Treated % Change* 
1 15.62 15.67 61.08 28.46 0.1171 0.1171 37.94 37.94 0.00 
2 25.43 25.49 69.39 66.47 0.0502 0.1171 89.90 38.54 -57.13 
3 29.32 29.36 58.12 38.95 0.0502 0.2007 90.65 22.68 -74.99 
4 34.93 34.98 29.24 23.55 0.0502 0.0502 91.94 91.96 0.01 
5 38.27 38.30 29.14 41.03 0.0836 0.0502 55.75 92.85 66.55 
6 48.72 48.71 100.00 100.00 0.0816 0.1020 59.24 47.39 -20.00 
7 49.20 49.17 54.90 45.66 0.1020 0.1224 47.49 39.57 -16.68 
8 52.21 52.29 20.20 32.87 0.0612 0.0816 80.14 60.13 -24.97 
9 56.14 56.22 25.13 30.32 0.1428 0.0816 34.96 61.55 75.07 
10 58.33 58.35 36.28 26.59 0.1020 0.2040 49.46 24.73 -50.00 
11 61.76 61.72 18.16 9.27 0.1020 0.2448 50.32 20.96 -58.34 
12 63.17 63.17 28.46 30.09 0.0816 0.1020 63.38 50.70 -20.00 
13 72.15 72.18 23.88 14.79 0.0816 0.1224 66.82 44.56 -33.32 
14 78.96 79.04 13.82 67.33 0.0816 0.0816 69.99 70.03 0.06 
15 91.98 91.97 40.23 22.05 0.1020 0.1428 62.25 44.46 -28.58 
16 Average crystallite size* 63.35 49.85 -21.31 
FWHM: Full width half maximum, *denotes the percentage change in the crystallite size of the Biofield Energy Treated sample with respect to the control 
sample. 
The PXRD diffractogram of the control and Biofield 
Energy Treated zinc chloride showed greater intensity at 
Bragg’s angle (2θ) equal to 48.7° (Table 1, entry 6). A sharp 
peak at 2θ equal to 16.58° (Figure 1) was observed in the 
control sample, whereas this peak was diminished in the 
Biofield Energy Treated sample. These results indicated the 
relative intensities of the PXRD peaks (Table 1) in the 
Biofield Energy Treated sample were significantly altered 
compared with the control sample. It has been found in the 
scientific literature that XRD relative intensity of each 
diffraction face on the crystalline compound changes 
according to the crystal morphology [45]. Thus, it is 
presumed that the energy transferred through the Biofield 
Energy Healing Treatment probably altered the shape and 
size of molecules, which might be responsible for an 
alteration in the relative intensities and crystallite size in the 
Biofield Energy Treated sample as compared to the control 
sample. 
Raza et al. reported that changes in XRD pattern 
provide the proof of polymorphic transitions [46, 47]. 
Crystal habit, size, and even polymorphic form of a drug 
have a significant effect on the drug solubility, dissolution, 
and bioavailability. It has been reported in the literature 
that alteration in the crystal morphology had the 
significant impact on in vitro dissolution rate, with 
prospective for improving bioavailability [41]. Hence, 
PXRD study revealed that the Biofield Energy Healing 
Treatment might introduced a new polymorphic form of 
zinc chloride, which could have improved bioavailability 
compared with the control sample. 
3.2. Particle Size Distribution (PSD) Analysis 
The particle size data (d10, d50, and d90) of both the control 
and Biofield Energy Treated zinc chloride were investigated 
and the results are presented in the Table 2. It was evident 
that the Biofield Energy Treatment has the ability to reduce 
the particle size (d10, d50, and d90) of zinc chloride with 
respect to the control sample. The size of the particles at 
below 10% level (d10), 50% level (d50), and 90% level (d90) 
were significantly decreased by 8.15%, 6.28%, and 5.26%, 
respectively in the Biofield Energy Treated sample compared 
to the control sample.  
Table 2. Particle size data (d10, d50, and d90) and surface area of the control 
and Biofield Energy Treated zinc chloride. 
Parameter d10 (µm) d50 (µm) d90 (µm) Surface area (m
2/g) 
Control 1.034 2.740 6.427 2.94 
Biofield Energy 
Treated 
0.946 2.568 6.089 3.15 
Percent change 
(%)* 
-8.15 -6.28 -5.26 7.14 
*denotes the percentage change in the particle size data (d10, d50, and d90) and 
surface area of the Biofield Energy Treated sample with respect to the 
control sample. 
The particle size and surface area have a major effect on 
dissolution of a compound in a solvent, because the 
surface energy influenced by the surface area and 
chemical affinity is the driving factor for dissolution 
efficiency [48, 49]. The surface area for both the control 
and Biofield Energy Treated zinc chloride samples was 
analyzed and the results are presented in Table 2. The 
control sample showed surface area of 2.94 m2/g and it 
was increased to 3.15 m2/g in the Biofield Energy Treated 
zinc chloride. The surface area of the Biofield Energy 
Treated sample significantly increased by 7.14% 
compared with the control sample.  
Poorly crystallized compounds possess more surface area 
and higher exchange capacities than well-crystallized 
compounds [50]. In addition, the variation of the crystal 
morphology in the Biofield Energy Treated sample, which 
was well-supported from PXRD data, may cause to alter the 
surface area of the Biofield Energy Treated zinc chloride 
compared with the control sample. It has been well 
established that the particle size, shape and surface area of 
pharmaceutical compounds have an important impact on 
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solubility, dissolution and in vivo bioavailability, as well as 
supports the designing of new drug delivery systems [51, 52]. 
Reducing the particle size and higher surface area would 
enhance the solubility of the solid particles, and consequently 
would increase the dissolution rate and bioavailability [53]. 
Thus, it is assumed that the Biofield Energy Treated zinc 
chloride might be dissolved and absorbed at a faster rate and 
may possibly have more bioavailability than untreated zinc 
chloride. 
3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
The FT-IR spectra of the control and Biofield Energy 
Treated samples of zinc chloride are presented in the Figure 
2. The characteristic peak were observed at 3903, 3589, 
3518, 1930, 1607, 992, and 510 cm-1 in the control FT-IR 
spectrum (Figure 2). On the other hand, the FT-IR spectrum 
of the Biofield Energy Treated zinc chloride showed the 
notable absorption bands at 3903, 3589, 3519, 1931, 1607, 
987, and 511 cm-1 (Figure 2). The strong and broad 
absorption band centered near 3589 cm-1 and the H-O-H 
bending motion at 1607 cm-1 that were due to the presence of 
the lattice water were found in both the control and Biofield 
Energy Treated FT-IR spectrum (Figure 2). Literature 
suggested that the metal-halide stretching absorption band for 
inorganic materials generally found in the 750-100 cm-1 
region [54]. In control spectrum, metal-halogen (Zn-Cl) 
stretching was shown at 510 cm-1, whereas in the Biofield 
Energy Treated sample at was found to be 511 cm-1. Overall, 
the characteristic molecular vibrational frequencies of the 
Biofield Energy Treated zinc chloride were not significantly 
changed compared with the control sample. 
 
Figure 2. FT-IR spectra of the control and Biofield Energy Treated zinc chloride. 
3.4. Ultraviolet-Visible Spectroscopy (UV-Vis) Analysis 
The UV-visible spectra of both the control and Biofield 
Energy Treated zinc chloride are presented in the Figure 3. 
The wavelength of the most intense UV-Vis absorbance 
(λmax) of the both the control and Biofield Energy Treated 
samples were observed in their UV-Vis spectra (Figure 3) 
at 196.0 nm with a minor shift of absorbance maxima 
from 2.0465 in the control sample to 2.0249 in the 
Biofield Energy Treated sample. The UV absorbance 
occurs due to the diverse type of energy transitions from 
the singlet to the singlet excited state such as σ→σ*, 
n→π*, and π→π*. These type of electronic transitions are 
occurred when the difference in energy between the lowest 
unoccupied molecular orbital (LUMO) and the highest 
occupied molecular orbital (HOMO) is significantly 
higher than the activation energy of the compound [55]. 
The UV-vis spectroscopic analysis of zinc chloride 
displayed no change in the λmax of the Biofield Energy 
Treated sample as compared to the control sample. Thus, 
the structural configuration or activation energy of the 
Biofield Energy Treated sample was not changed 
compared to the control sample. 
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Figure 3. UV-vis spectra of the control and Biofield Energy Treated zinc chloride. 
3.5. Differential Scanning Calorimetry (DSC) Analysis 
The DSC thermograms of the control and Biofield Energy 
Treated zinc chloride are presented in the Figure 4. The 
melting/decomposition temperature and enthalpy of 
fusion/decomposition of the control and Biofield Energy Treated 
zinc chloride are presented in the Table 3. The melting/fusion 
temperature was decreased by 0.29% in the Biofield Energy 
Treated zinc chloride (310.72°C) as compared to the control 
sample (311.63°C). The onset melting temperatures was 
decreased by 0.76% and the endset temperature was increased 
by 0.13% in the Biofield Energy Treated sample compared with 
the control sample. The latent heat of fusion or enthalpy of 
fusion (∆Hfusion) of the control and Biofield Energy Treated zinc 
chloride were 187.39 J/g and 370.48 J/g, respectively. The 
∆Hfusion of the Biofield Energy Treated sample was increased 
significantly by 97.71% compared with the control sample. 
Similarly, the decomposition temperature of the Biofield Energy 
Treated zinc chloride (385.81°C) was decreased by 0.28% 
compared to the control sample (386.88°C). The onset and 
endset decomposition temperatures of the Biofield Energy 
Treated sample were also decreased by 0.56% and 0.58%, 
respectively compared with the control sample. The enthalpy of 
decomposition (∆Hdecomposition) of the control and Biofield Energy 
Treated zinc chloride were 632.90 J/g and 535.42 J/g, 
respectively. The ∆Hdecomposition of the Biofield Energy Treated 
sample was significantly decreased by 15.40% compared with 
the control sample. This results indicated that the zinc chloride 
need more energy in the form of latent heat to undergo the 
process of melting after Biofield Energy Treatment. It is 
anticipated that Biofield Energy Treatment might influenced the 
internal energy in zinc chloride that leads to alteration of the 
melting/decomposition temperature and the enthalpy of 
fusion/decomposition and ultimately to change the thermal 
stability of the Biofield Energy Treated sample compared with 
the untreated sample. The enhanced thermal stability of a drug is 
an advantage in the maintenance of the product in long term 
storage condition throughout the shelf-life for any 
pharmaceutical formulations [56]. 
Table 3. The latent heat of fusion (J/g), enthalpy of decomposition (J/g) and melting/decomposition temperature (°C) values of the control and Biofield Energy 
Treated zinc chloride. 
Endothermic peak Description Tonset (°C) Tpeak (°C) Tendset (°C)  ∆H (J/g) 
Endothermic peak 
Control sample 300.67 311.63 315.49 187.39 
Biofield Energy Treated sample 298.39 310.72 315.91 370.48 
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Endothermic peak Description Tonset (°C) Tpeak (°C) Tendset (°C)  ∆H (J/g) 
% Change* -0.76 -0.29 0.13 97.71 
Exothermic peak 
Control sample 382.71 386.88 388.24 632.90 
Biofield Energy Treated sample 380.55 385.81 386.00 535.42 
% Change* -0.56 -0.28 -0.58 -15.40 
Tonset: Onset melting/decomposition temperature, Tpeak: Peak melting/decomposition temperature, Tendset: Endset melting/decomposition temperature, ∆H: 
Enthalpy of fusion/decomposition, *denotes the percentage change of the Biofield Energy Treated sample with respect to the control sample. 
 
Figure 4. DSC thermograms of the control and Biofield Energy Treated zinc chloride. 
4. Conclusions 
The current study revealed that The Trivedi Effect® - 
Energy of Consciousness Healing Treatment had the 
significant effects on the physical, structural, thermal, and 
behavioral properties of zinc chloride. The PXRD data 
displayed the significant alteration of the crystallite size and 
relative intensities of the XRD peaks in The Trivedi Effect® 
sample compared with the control sample. A sharp peak at 2θ 
equal to 16.58° was observed in the control sample, but it 
was disappeared in the treated sample. The average 
crystallite size of the treated sample was significantly 
reduced by 21.31% compared with the control sample. The 
particle size values at d10, d50, and d90 were significantly 
decreased by 8.15%, 6.28%, and 5.26%, respectively in the 
treated sample compared with the control sample. The 
surface area of the treated sample was significantly increased 
by 7.14% compared with the control sample. The DSC 
analysis exhibited that the melting and decomposition 
temperature were decreased by 0.29% and 0.28%, 
respectively in the treated zinc chloride compared to the 
control sample. The latent heat of fusion of the treated 
sample (370.48 J/g) was increased significantly by 97.71% 
compared with the control sample (187.39 J/g). The enthalpy 
of decomposition of the treated sample was significantly 
decreased by 15.40% compared with the control sample. The 
thermal analysis revealed that the zinc chloride need more 
energy in the form of latent heat to undergo the process of 
melting after Biofield Energy Treatment. Briefly, The Trivedi 
Effect® - Energy of Consciousness Healing Treatment might 
introduce a new thermally stable polymorphic form of zinc 
chloride that could be more soluble, bioavailable, and high 
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latent heat of fusion compared with the untreated compound. 
Hence, the Biofield Energy Treated zinc chloride would be 
very useful to design better nutraceutical and/or 
pharmaceutical formulations that might offer better 
therapeutic response against inflammatory diseases, 
immunological disorders, aging, stress, cancer, Wilson’s 
disease, viral diseases, parakeratosis, hypogeusia, anorexia, 
dysosmia, geophagia, hypogonadism, growth retardation, etc. 
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